Jove
Visualize
Contact Us

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remuscularizing the Failing Human Heart.

The New England journal of medicine·2026
Same author

Author Correction: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.

Nature·2026
Same author

Genome-wide CRISPRi screen identifies basigin loss as protective in cardiac hypoxia.

bioRxiv : the preprint server for biology·2026
Same author

The oligogenic inheritance test GCOD detects risk genes and their interactions in congenital heart defects.

Genome research·2025
Same author

A microphysiological system for screening lipid nanoparticle-mRNA complexes predicts in vivo heart transfection efficacy.

Nature biomedical engineering·2025
Same author

Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.

Nature·2025
Same journal

Choice, confounding, and consequence: twenty years of empiric antibiotics for neonatal early-onset sepsis.

Pediatric research·2026
Same journal

Comparing in-person and online recruitment methods in a prospective pediatric cohort study.

Pediatric research·2026
Same journal

Craniosynostosis and neurodevelopment: reframing a surgical condition as a global developmental risk.

Pediatric research·2026
Same journal

Neurologic sequelae of cerebral malaria and other forms of severe malaria in children.

Pediatric research·2026
Same journal

Home and in-hospital phototherapy as comparable select routine approach for neonatal hyperbilirubinemia.

Pediatric research·2026
Same journal

Polycyclic aromatic hydrocarbons and perinatal outcomes: a scoping review.

Pediatric research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 23, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Stem cell therapy for cardiac disease.

Harold S Bernstein1, Deepak Srivastava

  • 1Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA. harold.bernstein@ucsf.edu

Pediatric Research
|March 21, 2012
PubMed
Summary
This summary is machine-generated.

Stem cell therapy offers a promising new approach to treating heart failure, a condition often caused by congenital heart defects or cardiomyopathy. This innovative strategy aims to repair damaged heart muscle, potentially reversing previously terminal heart damage.

More Related Videos

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Related Experiment Videos

Last Updated: May 23, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Biotechnology

Background:

  • Congenital heart disease (CHD) is the most common birth defect, affecting 1% of newborns and often leading to heart failure.
  • Dilated cardiomyopathy, both genetic and acquired, is another major cause of pediatric heart failure.
  • The heart has limited regenerative capacity, making heart transplantation the primary but often inaccessible treatment for end-stage heart failure.

Purpose of the Study:

  • To explore stem cell therapy as a viable strategy for reversing heart damage.
  • To review potential sources of cardiac-specific stem cells.
  • To discuss advancements in enhancing stem cell efficacy and applications in cardiac repair.

Main Methods:

  • Discussion of various stem cell sources: mesenchymal, resident cardiac, embryonic, and induced pluripotent stem cells.
  • Examination of methods to improve stem cell engraftment and survival in damaged heart tissue.
  • Review of techniques for creating cardiac tissue patches, bioartificial tissues, and whole organs.

Main Results:

  • Stem cell therapy presents a realistic strategy for repairing myocardial injury, offering an alternative to heart transplantation.
  • Ongoing research focuses on optimizing stem cell integration and function within the cardiac environment.
  • Progress is being made in evaluating the functional recovery of cardiac tissue post-cellular transplantation in preclinical and clinical studies.

Conclusions:

  • Stem cell therapy holds significant potential for treating heart failure by regenerating damaged myocardium.
  • Further research and development in stem cell sources, delivery, and tissue engineering are crucial for clinical translation.
  • Cellular transplantation offers a new paradigm for managing heart conditions previously considered irreversible.